2025-21298Notice

Merck Gets Tax Edge for New Jersey Drug Experiments

Published Date: 11/26/2025

Notice

Summary

Merck, Sharp & Dohme LLC got the green light to do limited production of pharmaceutical research products at their Rahway, New Jersey site inside Foreign-Trade Zone 49. This approval lasts three years and requires Merck to prove after two years that their foreign ingredients come from safe, trusted countries. The process keeps things secure and helps Merck speed up important medicine research without extra costs for now.

No Economic Impacts Identified for this Document

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
11/26/2025

Department and Agencies

Department
Independent Agency
Agency
Commerce Department
Foreign-Trade Zones Board
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in